FINWIRES · TerminalLIVE
FINWIRES

$BOLD

4 stories mentioning BOLDUpdated 45d ago

Every FINWIRES story that references BOLD, newest first.

Sectors

Sector Update: Healthcare Stocks Higher Late Afternoon

Healthcare stocks rose late Tuesday afternoon, with the NYSE Healthcare Index adding 1.5% and the State Street Health Care Select Sector SPDR ETF (XLV) increasing 1.3%.The iShares Biotechnology ETF (IBB) advanced 0.7%.In sector news, the US Justice Department is expected to charge about 450 defendants in alleged healthcare fraud schemes worth more than $6.5 billion, marking its largest coordinated antifraud operation to date, The Wall Street Journal reported, citing federal officials.In corporate news, AbbVie (ABBV) shares gained 1.8% after it said Tuesday that the European Commission approved its therapy Maviret to treat acute hepatitis C virus infection in adults and children aged three years and older.Merck (MRK) shares rose 3.1%. The company said Monday its investigational antibody tulisokibart met primary and secondary endpoints in a phase 3 trial of people with moderately to severely active ulcerative colitis.GE HealthCare Technologies (GEHC) is positioned for accelerating growth, driven by improving innovation, order momentum, and backlog, RBC Capital Markets said in a note. RBC started coverage of the company with an outperform rating and an $80 price target. GE HealthCare shares climbed 4.8%.Boundless Bio (BOLD) shares surged 80% after the company said it signed a definitive merger agreement with privately held biotech firm Serapha Bio.

$ABBV$BOLD$GEHC$MRK
Sectors

Sector Update: Healthcare Stocks Advance in Afternoon Trading

Healthcare stocks rose Tuesday afternoon, with the NYSE Healthcare Index adding 1.4% and the State Street Health Care Select Sector SPDR ETF (XLV) increasing 1.2%.The iShares Biotechnology ETF (IBB) advanced 1.5%.In sector news, the US Justice Department is expected to charge about 450 defendants in alleged healthcare fraud schemes worth more than $6.5 billion, marking its largest coordinated antifraud operation to date, The Wall Street Journal reported, citing federal officials.In corporate news, GE HealthCare Technologies (GEHC) is positioned for accelerating growth, driven by improving innovation, order momentum, and backlog, RBC Capital Markets said in a note. RBC started coverage of the company with an outperform rating and an $80 price target. GE HealthCare shares climbed 4.6%.Eli Lilly (LLY) and Astellas Pharma have entered into two separate asset sale agreements with Sangamo Therapeutics as part of Sangamo's voluntary Chapter 11 reorganization, the genomic medicine company said Tuesday. Lilly shares added 0.4%.Boundless Bio (BOLD) shares surged 85% after the company said it signed a definitive merger agreement with privately held biotech firm Serapha Bio.

$BOLD$GEHC$LLY
Wire

Top Midday Gainers

Boundless Bio (BOLD) signed a definitive agreement with privately held biotech firm Serapha Bio in an all-stock merger, according to a statement Tuesday.Shares of Boundless surged 88% as intraday trading volume catapulted to over 57.5 million from a daily average of about 223,000.HeartSciences (HSCS) has agreed to merge with digital mining company Fortitude Mining in an all-stock deal, it said Tuesday.Shares jumped 52% amid a jump in intraday trading volume to over 126.9 million from a daily average of roughly 32,000.IBM (IBM) joined the OpenAI Daybreak Cyber Partner Program and launched a new application-security service that uses OpenAI's models to help enterprises identify and validate software vulnerabilities, it said late Monday.Shares rose 5.5% following an increase in intraday trading volume to over 9.3 million from a daily average of about 8.2 million.Price: $2.63, Change: $+1.23, Percent Change: +87.86%

$BOLD$HSCS$IBM
Sectors

Sector Update: Healthcare Stocks Mixed Pre-Bell Tuesday

Healthcare stocks were mixed pre-bell Tuesday, with the State Street Health Care Select Sector SPDR ETF (XLV) up 0.5% and the iShares Biotechnology ETF (IBB) 0.7% lower.Natera (NTRA) has received a Category 1 recommendation from the National Comprehensive Cancer Network for Signatera-guided adjuvant atezolizumab treatment in patients with muscle-invasive bladder cancer, the company said. Natera shares were down more than 2% premarket.Boundless Bio (BOLD) stock was up more than 79% after the company said it signed a definitive merger agreement with privately held biotech firm Serapha Bio in an all-stock merger.Armata Pharmaceuticals (ARMP) shares were up more than 10% after the company said it has received an additional $2.5 million in non-dilutive funding under a previously announced award from the Department of Defense.

$ARMP$BOLD$IBB$NTRA$XLV

Track with the FINWIRES app suite